Zdrowie i gospodarka · 25/04/1997

FDA Approves CellPro's CEPRATE SC Stem Cell Concentration System

The US Food and Drug Administration (FDA) has approved CellPro, Inc.'s application for premarket approval of the CEPRATE SC Stem Cell Concentration System, a medical device, under the Federal Food, Drug, and Cosmetic Act. The approval was granted by the FDA's Center for Biologics Evaluation and Research (CBER) on December 6, 1996.